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Context: Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but the 72	
genetic basis is largely unknown. Although DP is sometimes seen in relatives of patients with 73	
hypogonadotropic hypogonadism (HH), mutations in genes known to cause HH which segregate with 74	
the trait of familial self-limited DP have not yet been identified. 75	
Objective: To assess the contribution of mutations in genes known to cause HH to the phenotype of 76	
self-limited DP. 77	
Design, patients and setting: We performed whole exome sequencing in 67 probands and 93 relatives 78	
from a large cohort of familial self-limited DP, validated the pathogenicity of the identified gene 79	
variant in vitro and examined the tissue expression and functional requirement of the mouse homolog 80	
in vivo. 81	
Results:  A potentially pathogenic gene variant segregating with DP was identified in 1 of 28 known 82	
HH genes examined.  This pathogenic variant occurred in HS6ST1 in one pedigree and segregated 83	
with the trait in the six affected members with heterozygous transmission (p= 3.01 x 10-5). 84	
Biochemical analysis showed that this mutation reduced sulphotransferase activity in vitro. Hs6st1 85	
mRNA was expressed in peri-pubertal wild type mouse hypothalamus. GnRH neuron counts were 86	
similar in Hs6st1+/- and Hs6st1+/+ mice, but vaginal opening was delayed in Hs6st1+/- mice despite 87	
normal postnatal growth. 88	
Conclusions: We have linked a deleterious mutation in HS6ST1 to familial self-limited DP and show 89	
that heterozygous Hs6st1 loss causes DP in mice. In this study, the observed overlap in potentially 90	





Abnormal pubertal timing affects over 4% of adolescents and is associated with adverse health and 95	
psychosocial outcomes (1-3). However, in most patients with early or late onset of puberty, the 96	
underlying pathophysiology is unknown. Self-limited delayed puberty (DP) represents an extreme 97	
variant of normal pubertal timing and has been shown to cluster in families (4). Several groups have 98	
noted that DP segregates in an autosomal dominant pattern (4,5), suggesting mono- or oligo-genetic 99	
inheritance conferred by haploinsufficiency or a gain of function mutation. As such, pedigrees with 100	
familial DP represent an invaluable resource to investigate the genetic regulation of puberty onset.  101	
Significant insights into the genetic control of the hypothalamic-pituitary-gonadal (HPG) axis have 102	
come from the discovery of rare variants underlying conditions of GnRH deficiency, such as 103	
hypogonadotropic hypogonadism (HH) (6). Perturbed embryonic migration of GnRH neurons from 104	
nose to hypothalamus has been shown to cause HH in humans and in animal models (7,8). 105	
Alternatively, HH may arise through mutations that affect GnRH secretion or function in the presence 106	
of a normal GnRH neuron number in the hypothalamus (9).  107	
In view of the possible overlap between the pathophysiology of DP and conditions of GnRH 108	
deficiency, a few studies have examined the contribution of mutations in genes that cause HH to the 109	
pathogenesis of DP (10-12). Potentially pathogenic variants in a small number of genes causing HH 110	
(GNRHR, TAC3, TACR3, IL17RD and SEMA3A) were identified by whole exome sequencing (WES) 111	
in a few cases of self-limited DP, including those with constitutional delay of growth and puberty 112	
(13). Moreover, evidence from WES in our own cohort supports the hypothesis that mutations in 113	
genes which influence GnRH neuronal migration or development can cause self-limited DP (14). In 114	
this study, we assessed the contribution of mutations in genes known to cause HH to the phenotype of 115	






The patients selected for this study belong to a previously described and accurately phenotyped 121	
Finnish DP cohort, for which diagnosis is based on objective evidence of a delayed pubertal growth 122	
spurt rather than self-recall (15). Patients were referred with DP to specialist paediatric care in central 123	
and southern Finland from 1982-2004. All patients (n=492) met the diagnostic criteria for self-limited 124	
DP, defined as the onset of Tanner genital stage II (testicular volume >3 ml) >13.5 yrs in boys or 125	
Tanner breast stage II >13.0 yrs in girls (i.e. two SD later than average pubertal development) (16). 126	
Medical history, clinical examination, and routine laboratory tests were reviewed to exclude those 127	
with chronic illness. HH, if suspected, was excluded by spontaneous pubertal development at follow-128	
up. Normal fertility has been demonstrated in affected family members (5). Families of the DP 129	
patients were invited to participate via structured interviews and using archived height measurement 130	
records. The criteria for DP in probands’ family members were: 1) age at take-off; or 2) peak height 131	
velocity (PHV) occurring 1.5 SD beyond the mean, i.e. age at take-off exceeding 12.9 and 11.3 yrs, or 132	
age at PHV exceeding 14.8 and 12.8 yrs in males and females; or 3) age at attaining adult height more 133	
than 18 or 16 yrs, in males and females, respectively (15). Written informed consent was obtained 134	
from all participants. The study protocol was approved by the Ethics Committee for Pediatrics, 135	
Adolescent Medicine and Psychiatry, Hospital District of Helsinki and Uusimaa (570/E7/2003). UK 136	
ethical approval was granted by the London-Chelsea NRES committee (13/LO/0257). The study was 137	
conducted in accordance with the guidelines of The Declaration of Helsinki. 138	
Genetic Analysis  139	
Genetic analysis was performed in 67 probands with DP from those 67 families with the greatest 140	
number of affected individuals in our cohort (male n=57, female n=10, see Supplementary Figure 1), 141	
58 affected family members (male n=36, female n=22) and 35 of their unaffected family members 142	
(male, n=13, female n=22). WES was performed on DNA extracted from peripheral blood leukocytes 143	
of these 160 individuals, using a Nimblegen V2 or Agilent V5 platform and Illumina HiSeq 2000 144	
sequencing. The exome sequences were aligned to the UCSC hg19 reference genome. Picard tools 145	
and the genome analysis toolkit were used to mark PCR duplicates, realign around indels, recalibrate 146	
quality scores and call variants.  147	
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Variants were analysed and filtered for potential causal variants using filters for quality control, 148	
predicted function, minor allele frequency (MAF) and biological relevance (Figure 1). Filtering by 149	
MAF included only variants with MAF <1% in the 1000 Genomes database, the NHLBI exome 150	
variant server and the ExAC and gnomAD databases. Biological relevance filtering allowed 151	
prioritisation of variants according to our ‘HH genes’ list (Table 1), comprising genes known to be 152	
relevant to the phenotype of HH based on previously published studies and using pathway analysis 153	
with Genego MetaCore (Thomson Reuters). The segregation with trait filter retained only variants 154	
present in ≥ n-1 affected individuals (where n = number of affected individuals in a given pedigree) 155	
and not present in more than one unaffected individual (Table 1). 156	
Targeted exome sequencing (Fluidigm) of the remaining candidate gene post-filtering was performed 157	
in a further 42 families from the same cohort (288 individuals, 178 with DP; male=106, female=69 158	
and 110 controls; male=55, female=58, Figure 1), with filtering as in (14). Whole gene rare variant 159	
burden testing was performed post sequencing. Fisher’s exact test was used to compare the prevalence 160	
of deleterious variants in our cohort with the Finnish population, using the ExAC Browser (Exome 161	
Aggregation Consortium (ExAC), Cambridge, MA: http://exac.broadinstitute.org, accessed 162	
September 2015). For each gene, all variants from the ExAC database with minor allele frequency 163	
<2.5%, predicted to be deleterious by both Polyphen-2 (17) and SIFT (18), were included in the 164	
analysis, with each family in our cohort represented by the proband only. A multiple comparison 165	
adjustment was applied post hoc using the Benjamini & Hochberg method (19), as detailed in (14). 166	
All variants identified were confirmed via Sanger sequencing.  167	
In vitro assay of sulphotransferase activity 168	
The human HS6ST1 cDNA (IMAGE consortium accession ID BC099638) was obtained from 169	
Genecopoeia in a pReceiverM14a backbone (pReceiverM14a-WThHS6ST1). The p.Arg375His and 170	
p.Met404Val point mutations were introduced by PCR-mediated mutagenesis (Quickchange II, 171	
Agilent Technologies), using the following primers: Hs6st1_R375H_FOR 5’-172	
GCCTGAGGAGCCACGAGGAGCGTCT-3’, Hs6st1_R375H_REV 5’-173	
AGACGCTCCTCGTGGCTCCTCAGGC-3’ for p.Arg375His and Hs6st1_M404V_FOR 5'-174	
CCCACCGAGGACTACGTGAGCCACATCATTG-3', Hs6st1_M404V_REV 5'-175	
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CAATGATGTGGCTCACGTAGTCCTCGGTGGG-3' for p.Met404Val. Mutations were confirmed 176	
by Sanger sequencing. COS7 cells, at 90% confluency in 6-well plates, were transfected with 2 µg of 177	
wild-type or mutant plasmids using Fugene HD (Promega). After 48 h, cells were lysed with 50 mM 178	
Tris HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100. pH 7.4. The homogenates were stirred for 1 179	
hr and then centrifuged at 10,000 × g for 30 sec at 4 °C to clear debris. HS6ST1-FLAG fusion 180	
proteins were isolated from the supernatant using an anti-FLAG M2 affinity chromatography kit 181	
(A2220, Sigma). The purity of the eluted protein was checked by Coomassie Brilliant Blue (Thermo 182	
Fisher) staining of SDS-page electrophoretic gels. Protein relative amounts were calculated by 183	
densitometric analysis of Western blots with mouse monoclonal M1 anti-FLAG antibody (1:1000 184	
dilution, Sigma). 185	
Sulphotransferase activity was measured using R&D Systems’ colorimetric assay (EA003). Briefly, 186	
different amounts of purified HS6ST1 proteins were added to a mix of 0.2 mM 3'-phosphoadenosine-187	
5'-phosphosulfate (PAPS, donor), 1 mM N-acetylglucosamine (NAcGluc, acceptor) and 10 ng/ml 188	
inositol monophosphatase 3 (coupling enzyme) in a total volume of 50 µl of reaction buffer. The 189	
elution product of mock-transfected cells was used as negative control. The reaction was allowed to 190	
proceed for 20 min at 37◦C with inorganic phosphate (Pi) measured immediately after by the 191	
Malachite Green Method. Enzymatic activity was represented as percent of WT activity.  192	
Animals 193	
Animal procedures were performed in accordance with institutional and UK Home Office guidelines. 194	
The Hs6st1+/− mice have been described previously (20,21) and were maintained in a C57/Bl6J 195	
background by pairing with wild type partners.  Hs6st1+/+ and Hs6st1+/- female mice were checked 196	
daily for vaginal opening (VO) and weight after weaning, i.e. from 21 days of age (22). 197	
Histological analyses 198	
Peri-pubertal and adult mice were perfused with 4% formaldehyde in PBS and then brains and testis 199	
were dissected and post-fixed overnight at 4 °C. Testes were dehydrated, embedded in paraffin, 200	
microtome sectioned at 8 µm and stained with hematoxylin and eosin, as previously described (23).  201	
For in situ hybridisation (ISH) or immunostaining, brains were cryoprotected in 30% sucrose and 202	
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frozen in OCT compound (VWR). 12-µm thick serial sagittal and coronal cryosections were collected 203	
on Superfrost Plus slides (VWR) and incubated with anti-sense riboprobes for Gnrh (24) or Hs6st1 204	
(21). In some experiments, we combined ISH with GnRH immunofluorescence and used a different 205	
mouse Hs6st1 probe, which was generated by PCR-amplification from brain cDNA using 5’-206	
ACTGGACCGAACTCACCAAC-3’ and 5’-AACTCAGTGAGGCCGAAGAA-3’as primers and 207	
cloning into the dual promoter vector pGEM-T easy (Promega). Probes were generated as described 208	
(25). For immunoperoxidase staining, mouse 25-µm mouse brain cryosections were incubated with 209	
Bloxall (Vector Laboratories) to quench endogenous peroxidase activity before incubation with 210	
GnRH primary antibody (1:1000 in PBS, Immunostar) followed by incubation with biotinylated goat 211	
anti-rabbit antibody (1:400 in PBS; Vector Laboratories). Immunostaining was developed with the 212	
ABC kit (Vector Laboratories) and DAB (Sigma-Aldrich), as described (24). 213	
Image processing and quantification 214	
Images were acquired either using a Leica DM5500B microscope equipped with a DCF295 camera 215	
and DCViewer software (Leica) and then processed with Photoshop CS6 and Illustrator CS6 (Adobe) 216	
or acquired on an Axioskop2 Plus microscope (Zeiss) equipped with a TCH-5.0 ICE digital camera 217	
(TiEsseLab).  In some experiments, bright-field images of ISH patterns were converted to RGB 218	
colour mode for superimposition onto fluorescent images. GnRH-positive cells were counted on 50 219	
25-µm sections through the entire MPOA of each animal. To compare the abundance of GnRH-220	
positive neurites at the ME, we measured the pixel intensity of GnRH staining in 25-µm thick coronal 221	
sections through the entire ME.  222	
Statistical significance  223	
Data are expressed as mean ± standard error of the mean (SEM). Differences between groups were 224	
evaluated by 2-tailed student t-test and considered significant at p < 0.05. Statistical analysis was 225	
performed using Prism (GraphPad Software). 226	
 227	
Results 228	
Exome sequencing of families with self-limited delayed puberty identified an HS6ST1 variant 229	
Whole exome sequencing of 67 informative families from our large cohort with self-limited DP 230	
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identified 20 rare (MAF <1%) and predicted deleterious variants in 12 genes from a list of known HH 231	
genes (Table 1). However, after filtering for segregation with trait, only HS6ST1 232	
(ENSG00000136720, gene identification number 9394) was retained as a candidate gene (Figure 1). 233	
One proband and his affected relatives from one pedigree sequenced carried a rare and likely 234	
damaging HS6ST1 variant (NM_004807.2: c.1124G>A (rs182882999) p.Arg375His) which causes a 235	
non-conservative amino acid substitution in the coding sequence. This proband carried an additional 236	
potentially pathogenic variant in a known HH gene, FEZF1 (NM_ NM_001024613.3: c.1010T>A, 237	
p.Iso337Lys). However, this variant was not found in any other affected individual from this family 238	
and was, therefore, discounted due to lack of familial segregation. 239	
The rare heterozygous missense variant HS6ST1 (p.Arg375His) is predicted to be deleterious to 240	
protein function with 5/6 prediction tools, as the affected amino acid residue resides in a coiled-coil 241	
domain that is highly conserved among species, as revealed by the PhyloP and GERP score and a 242	
multiple sequence alignment (Supplementary Figure 2 and Supplementary Table 1). This specific 243	
variant was present at low MAF in some public databases, but whole gene rare variant burden testing 244	
showed significant enrichment of HS6ST1 rare predicted pathogenic variants in our cohort as 245	
compared to ethnically-matched controls from the ExAC database (adjusted p value = 3.01 x 10-5)) 246	
(Supplementary Table 2).  247	
After targeted exome sequencing, two additional variants in HS6ST1 were identified in three further 248	
affected probands (NM_004807.2: c199A>T (rs202247387) p.Lys67* and c585G>A p.Trp195*). 249	
However, Sanger sequencing did not validate the existence of these variants. No further rare, 250	
potentially damaging and trait segregating variants in HS6ST1 were identified by targeted sequencing.  251	
Pedigree with a potentially pathogenic HS6ST1 variant displayed an autosomal dominant 252	
inheritance pattern and classical self-limited DP. 253	
The pedigree with the p.Arg375His variant has several family members with typical features of self-254	
limited DP (Figure 2, panel A). The proband was first investigated for growth delay at 12.8 yrs, at 255	
which time his bone age was 11 yrs (Figure 2, panel B). Examination at this stage found him to be 256	
prepubertal, with bilateral testis volumes of 2 ml and no pubic hair development. His blood 257	
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biochemistry at that time showed a typical picture of functional HH. Spontaneous onset of puberty 258	
was observed around 14.3 yrs of age. Over the next 2.4 yrs, he achieved testis volume and 259	
testosterone levels within the normal adult range. His sister’s age at menarche was 15 yrs. Both 260	
siblings had normal birth weight and birth length. Their father and paternal uncle and aunt also had 261	
DP with delayed pubertal growth spurt. All family members with DP had self-reported normal 262	
olfaction. 263	
The HS6ST1 p.Arg375His mutant protein has reduced sulphotransferase activity in vitro. 264	
In vitro analysis of sulphotransferase function of the p.Arg375His mutant HS6ST1 protein (Figure 2, 265	
panel C) showed reduced activity at 39% of the wild type (WT) HS6ST1 protein (mean ± SD: 39.81± 266	
8.21, p<0.001). This reduction in enzymatic function is within the range seen with other pathogenic 267	
mutations in HS6ST1 found in patients with HH (26), and similar to that of the p.Met404Val mutant 268	
HS6ST1 protein (mean +/- SD: 28.8+/-1.46). This observation is consistent with the HS6ST1 269	
p.Arg375His mutation as causative in self-limited DP. 270	
Hs6st1 is expressed within the adult hypothalamus and olfactory bulbs 271	
In the adult brain, GnRH neurons are scattered in a bilateral continuum between the olfactory bulb 272	
(OB) and the medial preoptic area (MPOA) of the hypothalamus, where most cell bodies reside (27). 273	
We found that Hs6st1 is highly expressed in the granular, mitral and glomerular layers of the adult 274	
OB (Figure 3, panel A) and diffusely in the MPOA (Figure 3, upper panel in B).  Hs6st1 expression 275	
was also observed in the arcuate nucleus (ARC), which harbours neurons that regulate GnRH 276	
secretion (Figure 3, lower panel in B). However, Hs6st1 mRNA did not localise to GnRH+ neurons 277	
(Figure 3, panel C). These observations suggest that Hs6st1 is expressed by hypothalamic cells that do 278	
not correspond to GnRH neurons. 279	
Normal positioning and number of GnRH neurons in the MPOA of Hs6st-1 heterozygous mice. 280	
To determine whether HS6ST1 is required for the normal development of the GnRH neuron system, 281	
we compared mice heterozygous for a Hs6st1 null allele (Hs6st1+/-) to their wild type littermates 282	
(Hs6st1+/+). However, there were no gross differences in brain or OB anatomy between the genotypes 283	
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(Figure 4, panels A-B). Moreover, there were no obvious differences in the positioning and number of 284	
GnRH neurons in the MPOA (Figure 4, panels C-D; number of GnRH+ cells:  Hs6st1+/- 341.2±24.2 285	
vs. Hs6st1+/+ 378.3±30.2, n=5 each; p=0.37). GnRH neurons in Hs6st1+/- mice also projected 286	
similarly to the median eminence (ME), the site where they normally release GnRH into the portal 287	
blood vessels of the pituitary gland; moreover, the pixel intensity of GnRH-stained neurites was 288	
similar in both genotypes (Figure 4, panels E-F; % stained neurite area: Hs6st1+/+ 2.9±0.4 vs. 289	
Hs6st1+/- 3.1±0.3, n=5 each; p=0.09). 290	
Hs6st1+/- mice show significantly delayed puberty onset 291	
To determine whether heterozygous HS6ST1 deficiency is sufficient to cause DP, we compared the 292	
timing of puberty in Hs6st1+/- and Hs6st1+/+ female mice by identifying the day of VO, a proxy 293	
measurement for pubertal activation of the HPG axis in mice (22).  We found that VO was delayed by 294	
on average 1.88±0.82 days in Hs6st1+/- compared to Hs6st1+/+ females (Figure 5, panel A, left; 295	
postnatal day (P) of VO: Hs6st1+/+ 30.2±0.7, n=12, vs. Hs6st1+/- 31.9±0.5, n=13; p=0.04; mice were 296	
pooled form 6 different litters). DP in Hs6st1+/- females was not due to overall delayed development, 297	
as they were not smaller than Hs6st1+/+ littermate females around the time of VO (weight at P30: 298	
Hs6st1+/+14.12±0.58 g, n=12, vs. Hs6st1+/-13.67±0.58 g, n=13; p=0.29). Instead, and consistent with 299	
their DP and thus older age at VO in the Hs6st1+/- females, there was an insignificant trend towards 300	
greater weight at the time of VO in Hs6st1+/- compared to Hs6st1+/+ females within the cohort 301	
examined (Figure 5, panel A, right; body weight on the day of VO: Hs6st1+/+ 14.9±0.3 g, n=12, vs. 302	
Hs6st1+/- 15.5±0.3 g, n=13; p=0.06). 303	
Despite DP, the fertility of young adult Hs6st1+/- males and females of both sexes appeared normal, 304	
because they produced litters without obvious delay and of normal litter size when paired to wild type 305	
mice at 4-6 months of age (litter size: Hs6st1+/- x Hs6st1+/+: 7.2±0.95 pups per litter in 6 litters, vs. 306	
Hs6st1+/+ x Hs6st1+/+ 7.3±0.71 pups per litter in 7 litters; p=0.89; Hs6st1+/- mice were born at the 307	
expected Mendelian ratio). In agreement with the ability to father litters of normal size, testes size was 308	
similar in young adult Hs6st1+/- and Hs6st1+/+ males (Figure 5, panel B; P35 testes length in mm: 309	
Hs6st1+/- 8.30±0.16, n=6, vs. Hs6st1+/+ 8.31±0.17, n=8; p=0.97). Moreover, testes showed normal 310	
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organisation of germ cells and interstitial Leydig cells and contained a similar number of seminiferous 311	
tubules per area (Figure 5, panels B,C; number of seminiferous tubule number per mm2: Hs6st1+/+ 312	
14.53±0.91 vs. Hs6st1+/- 14.69±0.62; n=5 each; p=0.88). Together, these findings show that HS6ST1 313	
haploinsufficiency delays puberty in mice without compromising fertility in the adult. 314	
 315	
Discussion 316	
The inheritance of self-limited DP is under strong genetic influence, with clear autosomal dominant 317	
segregation in many families with or without complete penetrance (4), and thus represents a useful 318	
basis for the investigation of puberty genetics (5). However, only a few genes responsible for self-319	
limited DP have been identified. In view of the possible overlap between the pathophysiology of DP 320	
and HH, screening self-limited DP patients for mutations in known HH genes appears a prudent 321	
strategy; however, minimal genetic overlap between the two conditions has been identified to date 322	
(13). Additionally, there have been some observed differences in inheritance patterns and penetrance 323	
between the two conditions (28). In HH, over 40 different genes have been identified and incomplete 324	
penetrance is often seen within pedigrees, leading to a wide spectrum of phenotypes (29-31). As the 325	
understanding of the genetic basis of both self-limited DP and HH improves, it is likely that genetic 326	
testing will be able to help establish a definitive diagnosis in adolescent patients presenting with 327	
delayed onset of puberty.  328	
Here, we have identified a deleterious mutation, p.Arg375His, in the HH gene HS6ST1 as the likely 329	
causal factor for self-limited DP in one pedigree from our cohort of patients with familial DP.  330	
HS6ST1 mutations have been previously identified in up to 2% of patients with idiopathic HH 331	
(26,32), but have not previously been reported in pedigrees segregating with the trait of self-limited 332	
DP. Our in vitro analysis showed that the HS6ST1 p.Arg375His mutation had reduced 333	
sulphotransferase activity, comparable to previously published mutations in this gene in patients with 334	
HH (26). Taken together, these results suggest a working model in which HS6ST1 heterozygosity 335	
causes self-limited DP, whilst potentially HS6ST1 homozygosity or a ‘second-hit’ in a separate gene, 336	
would produce the phenotype of HH.  337	
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Our studies in a murine model corroborate heterozygous Hs6st1 deficiency as a cause of delayed 338	
pubertal timing without compromised fertility. Thus, Hs6st1+/− mice were born at normal Mendelian 339	
ratios without obvious defects in GnRH neuron or testes development, but females showed delayed 340	
VO. The question of sex bias in self-limited DP is an interesting one, as it is diagnosed in up to 83% 341	
of boys and 30% of girls presenting with pubertal delay (33-35).	The underlying reasons for this 342	
gender difference are not clear. However, this difference may be due, in part, to ascertainment bias. 343	
Indeed, a previous study has shown a near equal sex ratio consistent with autosomal dominant 344	
inheritance when all of the affected individuals from our large cohort were examined, as opposed to 345	
the probands only (5). 346	
In our murine model of Hs6st1+/− mice, we did not find any evidence of a sex difference in anatomical 347	
studies. In this study only females were examined for timing of pubertal onset (VO), as VO is a very 348	
robust marker of pubertal onset in female mice. Male mice were not assessed for the timing of 349	
puberty, but the adult male mice had normal testicular morphology including the presence of 350	
spermatogenesis. Normal spermatogenesis is an excellent marker in males for reproductive 351	
competence and excludes GnRH deficiency. In females mice the reproductive competence was 352	
assessed as fertility of the females. With these methods GnRH deficiency was excluded both in male 353	
and female Hs6st1+/− mice. Importantly, mice deficient in Hs6st1 were not significantly smaller or 354	
lighter than their wild type littermates, excluding poor growth as the underlying cause for pubertal 355	
delay. The viability of Hs6st1+/− mice is in contrast to that of Hs6st1 knockout (Hs6st1−/−) mice, which 356	
could not be examined for puberty defects due to embryonic lethality (36).  357	
Our expression studies in mice indicate that Hs6st1 is expressed in several tissues relevant to normal 358	
GnRH neuron migration or function, including the OB and the MPOA, ARC and PVN of the 359	
hypothalamus. However, we did not identify any obvious abnormalities in OB morphology, GnRH 360	
neuron number in the MPOA or in GnRH neuron innervation of the ME in Hs6st1+/- mice. Instead, 361	
Hs6st1 expression in the ARC and PVN, where kisspeptin neurons and tanycytes modulate GnRH 362	
secretion and function (37,38), raises the possibility that HS6ST1 haploinsufficiency affects the 363	
regulation of GnRH neuron activity or other relevant downstream pathways.  364	
	 15	
Hs6st1 is required for the function of Anos1 (also known as Kal1) and Fgfr1, two genes that are 365	
required for normal HPG	axis function (26). In a C. elegans model, Hs6st1 regulates neural branching 366	
in concert with Anos1 and Fgfr1 (26). Moreover, Anos1 is also able to enhance Fgfr1 signalling in a 367	
HS-dependent manner in an immortalised human cell model of GnRH neurons, and it has been 368	
proposed that this interaction promotes olfactory and GnRH neuron development (39). However, 369	
Hs6st1 mutations may also impact on the HPG axis via Anos1-independent pathways, as HS 370	
modifications of many different proteoglycans in the extracellular matrix have the potential to affect 371	
multiple signalling pathways (40) previously implicated in the neuroendocrine control of fertility (41). 372	
In summary, we have identified a new pathogenic mutation in HS6ST1 as the likely cause of DP in a 373	
pedigree from our extensive patient cohort, with no other pathogenic mutations in genes known to 374	
cause HH identified in our cohort. These findings suggest that, with the exception of a few genes like 375	
HS6ST1, the genetic background of HH and DP is either largely different or is due to mutations in as 376	
yet undiscovered genes. Our findings differ from those in previous publications, in which up to 14% 377	
of DP probands were reported to carry potentially pathogenic variants in HH genes (13). However, 378	
previous results have not been adjusted for segregation with the DP trait within families, nor have the 379	
variants identified in these previous studies been tested for pathogenicity, and thus prior estimates of 380	
HH mutation rates in DP patients may have been an over-estimation. In agreement, prior to 381	
adjustment for segregation, our results suggested that 17.9% of DP probands had potentially 382	
pathogenic variants in HH genes, highlighting the value of familial data in identification of causal 383	
variants in a condition such as DP. Although further pedigrees with familial DP need to be studied to 384	
identify additional causative genes and provide accurate estimates of the genetic HH and DP overlap, 385	
our findings provide evidence that perturbations in a single allele of a gene regulating the HPG axis is 386	
sufficient to cause self-limited DP. In contrast, available evidence suggests that more deleterious 387	
alterations in the same gene, or in combination with additional genes, are required to cause more 388	
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Figure 1 – Flowchart of WES (whole exome sequencing) filtering strategy to identify HS6ST1.  565	
Whole exome sequencing was performed on DNA extracted from peripheral blood leukocytes of 160 566	
individuals from our cohort (67 DP probands, 58 DP relatives and 35 controls). The exome sequences 567	
were aligned to the UCSC hg19 reference genome. Picard tools and the genome analysis toolkit were 568	
used to mark PCR duplicates, realign around indels, recalibrate quality scores and call variants. 569	
Potential causal variants were identified using filters for quality control, predicted functional 570	
annotation, minor allele frequency (MAF), biological relevance (i.e. ‘HH gene’ list) and segregation 571	
with trait (see methods and table 1 for further information on filtering criteria). Targeted exome 572	
sequencing using a Fluidigm array of one candidate gene was then performed in a further 42 families 573	
from the same cohort (288 individuals, 178 with DP and 110 controls). Variants identified via 574	
targeted re-sequencing were filtered using the same criteria as the whole exome sequencing data, with 575	
additional rare variant burden testing. Functional annotation of the variants is as described in methods. 576	
DP – delayed puberty.  577	
 578	
Figure 2 – Pedigree and clinical details of a patient with a p.Arg375His mutation in HS6ST1 579	
that impairs sulphotransferase activity  580	
A: Pedigree of the proband with the p.Arg375His mutation. Squares indicate male family members, 581	
circles female family members. Black symbols represent clinically affected family members, grey 582	
symbols represent family members with unknown phenotype, clear symbols represent unaffected 583	
individuals. The arrow labelled ‘P’ indicates the proband in the family. A horizontal black line above 584	
or adjacent to an individual’s symbol indicates that they are heterozygous for the p.Arg375His 585	
mutation as identified by either whole exome sequencing or Fluidigm array, and verified by Sanger 586	
sequencing.  587	
B: Clinical details of the proband with the p.Arg375His mutation. Height chart for the proband shows 588	
reduction in growth velocity from 12 yrs of age, with associated delayed bone age shown in red. The 589	
subject was prepubertal until 14.1 yrs of age. This was followed by spontaneous onset of puberty and 590	
subsequent development over 2 yrs to normal adult testosterone levels and testicular volume. T vol – 591	
testicular volume, G – Tanner genital stage, Ph – Tanner pubic hair stage, LH – luteinising hormone, 592	
FSH – follicular stimulating hormone, T – testosterone. 593	
C: Sulphotransferase activity assay. The p.Arg375His mutation reduces HS6ST1 sulphotransferase 594	
activity. Relative specific activity (mean +/- SD) of recombinant WT or mutant (p.Arg375His or 595	
p.Met404Val) HS6ST1 proteins are shown. All assays were done as three independent biological 596	
repeats (n=3 for each experiment) using equal amounts of protein. *** p<0.001 597	
 598	
Figure 3. Hs6st1 mRNA expression in GnRH neuronal territories on postnatal day (P) 35. 599	
A: Coronal sections of adult mouse OB were labelled for Hs6st1 by in situ hybridisation The squared 600	
box in the left image is shown at higher magnification on the right side. 601	
B: Contiguous coronal sections of adult mouse hypothalamus representing the MPOA (upper panels) 602	
and the ME (lower panels) were labelled for Gnrh and Hs6st1 by in situ hybridisation; arrowheads 603	
indicate the Hs6st1 expression in the arcuate nucleus and ME.  604	
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C: Hs6st1 ISH (green) of coronal sections from P35 MPOA followed by immunolabeling for GnRH 605	
(red) revealed no expression of Hs6st1 in GnRH-positive neurons (example of GnRH neuron is 606	
indicated with a solid arrowhead). 607	
Scale bars: 125 µm (A, B upper panels), 50 µm (B lower panels), 25 µm (C). Abbreviations: OB, 608	
olfactory bulb; GL, glomerular layer; MI, mitral layer; GR, granular layer; MPOA, medial preoptic 609	
area; ME, median eminence; 3v, third ventricle; ARC, arcuate nucleus.  610	
 611	
Figure 4 – Hs6st1+/- mice showed no defects in olfactory bulbs nor in the number and 612	
projections of GnRH neurons. 613	
(A-B) Perfused adult Hs6st1+/+ and Hs6st1+/- brains were dissected, photographed and showed similar 614	
olfactory bulb structure in both genotypes. 615	
(C-D) Coronal sections of adult mouse MPOA were immunostained for GnRH; arrowheads indicate 616	
examples of GnRH neurons that are normally present both in Hs6st1+/- mice and WT.  617	
 (E-F) Immunostaining for GnRH in coronal sections of adult mouse ME shows that GnRH neurons 618	
project similarly to the ME in Hs6st1+/+ and Hs6st1+/- mice.  619	
Scale bar: 3 mm (A, B), 125 µm (C, D), 50 µm (E, F). Abbreviations: MPOA, medial preoptic area; 620	
ME, median eminence; 3v, third ventricle. Arrows demonstrate representative GnRH cell bodies. 621	
 622	
 623	
Figure 5 - Peri-pubertal female Hs6st1+/- mice show delayed vaginal opening while young adult 624	
male Hs6st1+/- mice showed normal testes morphology. 625	
(A) Age (left graph) and weight (right graph) at the time of the vaginal opening in female Hs6st1+/+ 626	
(n=12) and Hs6st1+/- (n=13) mice. Values for littermates are shown in the same colour. * indicates 627	
p<0.05 628	
(B-C) Hs6st1+/+ and Hs6st1+/- mice have similar testes size (upper panels of B), normal 629	
spermatogenesis after H&E staining of paraffin sections (lower panels of B) and similar number of 630	
seminiferous tubules (C).  631	





Gene No. of rare and predicated damaging variants filtered from 
whole exome sequencing data 
 Not Segregating with the 
DP trait  
Segregating with the DP trait 
ANOS1 0 0 
AXL 3 0 
CHD7 3 0 
DAX1 0 0 
FEZF1 3 0 
FGF8 0 0 
FGFR1 2 0 
GNRH1 0 0 
GNRHR 0 0 
HESX1 0 0 
HS6ST1 1 1 
KISS1 0 0 
KISS1R 0 0 
LEP 0 0 
LEPR 0 0 
LHX3 1 0 
LHX4 1 0 
NELF 0 0 
PCSK1 0 0 
PROK2 0 0 
PROKR2 2 0 
PROP1 1 0 
SEMA3A 0 0 
SF1 0 0 
SPRY4 1 0 
TAC3 1 0 
TAC3R 0 0 
WDR11 1 0 
 636	
Table 1 – HH gene filtering 637	
28 ‘HH genes’, mutations in which have been identified as causal or potentially causal in patients 638	
with GnRH deficiency, used for filtering post whole exome sequencing. Details given of number of 639	
variants in these genes identified in 67 probands with DP after whole exome sequencing. Variants are 640	
divided into those which were found to segregate with the DP trait within cohort pedigrees and those 641	























Functional annotation of 
variants
20 variants in 12 genes (see table 1)
Segregation with trait 
1 variant in 1 gene - HS6ST1
1 gene (HS6ST1) with 1 variant
Targeted exome 
sequencing 
Sanger sequencing for 
verification
1 gene (HS6ST1) in additional 288 individuals (42 families, 178 with DP, 
110 unaffected)
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